EP1586337
The local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.4.2005EP published:
21.6.2017EP application number:
05252315.6
EPO information:
European Patent Register
Max expiry date:
13.4.2025
Title:
The local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque
Timeline
Today
14.4.2005EP application
21.6.2017EP Publication
Owner
Name:
Cordis CorporationAddress:
14201 N.W. 60th Avenue, 33014, Miami Lakes,Florida, US
Inventor
Name:
Falotico, RobertAddress:
Belle Mead, NJ, US
Priority
Number:
826058Date:
15.4.2004Country:
US
Classification
Categories:
A61F 2/91, A61L 31/16